Home Effects of gestational and lactational choline deprivation on brain antioxidant status, acetylcholinesterase, (Na+,K+)- and Mg2+-ATPase activities in offspring rats
Article
Licensed
Unlicensed Requires Authentication

Effects of gestational and lactational choline deprivation on brain antioxidant status, acetylcholinesterase, (Na+,K+)- and Mg2+-ATPase activities in offspring rats

  • Charis Liapi , Irini Feskou , Apostolos Zarros , Panagiota Galanopoulou and Stylianos Tsakiris
Published/Copyright: May 7, 2007
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 5

Abstract

Background: Choline plays an important role in brain development. Choline-deficient diet (CDD) is known to produce (among other effects) a decrease in acetylcholine in rat brains. The aim of our study was to investigate how CDD administration during gestation and lactation could affect total antioxidant status (TAS) and activities of acetylcholinesterase (AChE), (Na+,K+)- and Mg2+-ATPase in the brains of both male and female newborn and suckling (21-day-old) rats.

Methods: Three different experiments were performed. Whole brains were obtained from: (a) newborn rats following gestational CDD (experiment I); (b) 21-day-old rats following gestational but not lactational CDD (experiment II); and (c) 21-day-old rats following gestational and lactational CDD (experiment III). Enzyme activities and TAS were measured spectrophotometrically.

Results: In choline-deprived (CD) newborn rats, TAS and AChE and Na+,K+-ATPase activities were signi-ficantly reduced by 23%, 24% and 50%, respectively, in the brains of both sexes. Gestational CDD caused only a decrease in TAS (−27%, p<0.001) in suckling rat brains in both sexes. No changes were observed for the other enzyme activities. Moreover, gestational and lactational CDD also led only to a decrease in TAS (−24%, p<0.001) in the suckling rat brains of both sexes. Mg2+-ATPase activities showed no changes after any of the experimental procedures.

Conclusions: Our data suggest that the lower enzyme activities in newborn CD brains were restored to normal after 21 days of either normal or CDD lactation, possibly due to novel synaptogenesis, endogenous neuroregulation, and/or to other substances acquired by lactation. The increase in homocysteine concentration due to choline deficiency reported in the literature may be the cause of the low antioxidant capacity observed in offspring rat brains. Brain Na+,K+-ATPase inhibition (induced by CDD) could result in modul-ations of neural excitability, metabolic energy production and neurotransmission.

Clin Chem Lab Med 2007;45:651–6.


Corresponding author: Stylianos Tsakiris, PhD, Associate Professor, Department of Experimental Physiology, Medical School, University of Athens, P.O. Box 65257, 15401 Athens, Greece Phone: +30-210-7462662, Fax: +30-210-7462571,

Received: 2006-10-22
Accepted: 2007-2-19
Published Online: 2007-05-07
Published in Print: 2007-05-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. 6th Conference on Homocysteine Metabolism, World Congress on Hyperhomocysteinemia, Saarbruecken/Germany June 5-9, 2007
  2. The role of ethylenediamine tetraacetic acid (EDTA) as in vitro anticoagulant for diagnostic purposes
  3. Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens
  4. Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study
  5. Association of lipase lipoprotein polymorphisms with myocardial infarction and lipid levels
  6. Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common α-thalassemia point mutations and deletions
  7. HLA-DQA1 and -DQB1 allele typing in southern Taiwanese women with breast cancer
  8. Association of a polymorphism in the promoter of the cellular retinoic acid-binding protein II gene (CRABP2) with increased circulating low-density lipoprotein cholesterol
  9. Frequency of two human glutathione-S-transferase omega-1 polymorphisms (E155 deletion and E208K) in Ovambo and Japanese populations using the PCR-based genotyping method
  10. Transthyretin amyloidosis in a patient of Iranian-Jewish extraction: a second Israeli-Jewish case
  11. Relationship between neurological outcome and early oxidative changes in erythrocytes in head injury patients
  12. Mesothelin family proteins and diagnosis of mesothelioma: analytical evaluation of an automated immunoassay and preliminary clinical results
  13. Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome
  14. A simple high-throughput method for the determination of plasma methylmalonic acid by liquid chromatography-tandem mass spectrometry
  15. Effects of gestational and lactational choline deprivation on brain antioxidant status, acetylcholinesterase, (Na+,K+)- and Mg2+-ATPase activities in offspring rats
  16. Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours
  17. Measurement of calcitonin by immunoassay analyzers
  18. Interference in a homogeneous assay for low-density lipoprotein cholesterol by lipoprotein X
  19. Quality indicators and specifications for key processes in clinical laboratories: a preliminary experience
  20. Analytical and clinical performance of three natriuretic peptide tests in the emergency room
  21. Quality of serum creatinine measurement in light of EQA programs
  22. Decreased plasmalogen concentration as a surrogate marker of oxidative stress in patients presenting with acute coronary syndromes or supraventricular tachycardias
  23. Comparison between AlaTOP and IP8 inhalant panels on the Immulite 2000 analyzer
  24. External quality assessment of urinary methylmalonic acid quantification – results of a pilot study
Downloaded on 5.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.118/html
Scroll to top button